Therapeutic Asset Ratings

184 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Nintedanib Refractory Acute Myeloid Leukemia	Northwestern University	P2	BB (64)
PANITUMUMAB Refractory Colorectal Cancer	Northwestern University	P2	BB (64)
Inno-206 Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation	Northwestern University	P2/3	BB (64)
Inno-206 Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Northwestern University	P2/3	BB (64)
PREDNISONE TABLETS Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation	Northwestern University	P2/3	BB (64)
PREDNISONE TABLETS Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Northwestern University	P2/3	BB (64)
VINCRISTINE SULFATE Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation	Northwestern University	P2/3	BB (64)
VINCRISTINE SULFATE Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Northwestern University	P2/3	BB (64)
Carboplatin Gliosarcoma	Northwestern University	P2	B (63)
Venetoclax Richter Syndrome	Northwestern University	P2	B (63)
Brentuximab Vedotin Enteropathy Associated T-cell Lymphoma	Northwestern University	P2	B (62)
Z/E 4-HYDROXY TAMOXIFEN Ductal Breast Carcinoma In Situ	Northwestern University	P2	B (62)
Brentuximab Vedotin Angioimmunoblastic T-cell Lymphoma	Northwestern University	P2	B (61)
Tranexamic Acid Blood Loss	Northwestern University	P3	B (60)
Tranexamic Acid Femoro Acetabular Impingement	Northwestern University	P3	B (60)
Tranexamic Acid Hip Impingement Syndrome	Northwestern University	P3	B (60)
Tranexamic Acid Hip Injuries	Northwestern University	P3	B (60)
Tranexamic Acid Hip Pain Chronic	Northwestern University	P3	B (60)
Cytosin-Arabinosid Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder	Northwestern University	P2	B (60)
Eloxatin Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder	Northwestern University	P2	B (60)
Epcoritamab Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder	Northwestern University	P2	B (60)
Epcoritamab Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder	Northwestern University	P2	B (60)
Epirubicin Nodal Peripheral T-Cell Lymphoma With TFH Phenotype	Northwestern University	P2	B (60)
Epirubicin Recurrent Enteropathy-Associated T-Cell Lymphoma	Northwestern University	P2	B (60)
Epirubicin Recurrent Hepatosplenic T-Cell Lymphoma	Northwestern University	P2	B (60)

Showing 26 to 50 of 184 assets

PreviousPage 2 of 8Next